These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 17522264)

  • 1. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy.
    Kelly DJ; Chanty A; Gow RM; Zhang Y; Gilbert RE
    J Am Soc Nephrol; 2005 Jun; 16(6):1654-60. PubMed ID: 15843473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
    Kelly DJ; Zhang Y; Hepper C; Gow RM; Jaworski K; Kemp BE; Wilkinson-Berka JL; Gilbert RE
    Diabetes; 2003 Feb; 52(2):512-8. PubMed ID: 12540629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
    Kelly DJ; Cox AJ; Tolcos M; Cooper ME; Wilkinson-Berka JL; Gilbert RE
    Kidney Int; 2002 Jan; 61(1):31-9. PubMed ID: 11786082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney disease.
    Kelly DJ; Edgley AJ; Zhang Y; Thai K; Tan SM; Cox AJ; Advani A; Connelly KA; Whiteside CI; Gilbert RE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1782-90. PubMed ID: 19155535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
    Sassy-Prigent C; Heudes D; Jouquey S; Auberval D; Belair MF; Michel O; Hamon G; Bariety J; Bruneval P
    Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.
    Lee EY; Shim MS; Kim MJ; Hong SY; Shin YG; Chung CH
    Exp Mol Med; 2004 Feb; 36(1):65-70. PubMed ID: 15031673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
    Gilbert RE; Kelly DJ; Cox AJ; Wilkinson-Berka JL; Rumble JR; Osicka T; Panagiotopoulos S; Lee V; Hendrich EC; Jerums G; Cooper ME
    Diabetologia; 2000 Nov; 43(11):1360-7. PubMed ID: 11126403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies.
    Moravski CJ; Skinner SL; Stubbs AJ; Sarlos S; Kelly DJ; Cooper ME; Gilbert RE; Wilkinson-Berka JL
    Am J Pathol; 2003 Jan; 162(1):151-60. PubMed ID: 12507898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
    Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
    Tsuchida K; Makita Z; Yamagishi S; Atsumi T; Miyoshi H; Obara S; Ishida M; Ishikawa S; Yasumura K; Koike T
    Diabetologia; 1999 May; 42(5):579-88. PubMed ID: 10333051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA; da Silva CG; Costa RS; Coimbra TM
    Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of angiostatin in diabetic nephropathy.
    Zhang SX; Wang JJ; Lu K; Mott R; Longeras R; Ma JX
    J Am Soc Nephrol; 2006 Feb; 17(2):475-86. PubMed ID: 16394111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
    Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.
    Kelly DJ; Skinner SL; Gilbert RE; Cox AJ; Cooper ME; Wilkinson-Berka JL
    Kidney Int; 2000 May; 57(5):1882-94. PubMed ID: 10792607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.